BRIEF-Valeant CEO says will get back to acquisitions - but not next year

Tue Dec 15, 2015 8:52am EST
 
Email This Article |
Share This Article
  • Facebook
  • LinkedIn
  • Twitter
| Print This Article
[-] Text [+]

Dec 15 (Reuters) - Valeant Pharmaceuticals International Inc

* CEO says will get back to acquisitions, but not next year, when it will focus on paying down debt instead - CNBC

* CEO says will spend 7 to 8 percent of sales on research and development in 2016 - about half the level of typical big pharma companies and up from previous spending - CNBC

* CEO says will spend $400 to $500 million on R&D (Reporting By Caroline Humer)